Skip to main content

The Big Fish, Part II: Privately Held Texas-Based Biomedical Companies with Annual Revenues Exceeding $10 Million

In my previous post I had assembled a list of Texas-based LifeSci/MedTech companies listed on the two major US stock exchanges, NYSE and NASDAQ [Note: I've added an additional company, Hanger, Inc., to the list since originally publishing the post]. I felt this was a good start, but I realized I'd also have to identify the large privately held companies in order to get a really good sense of who the major players are in the Texas biomedical industry.

I decided to define "largeness" as a function of the company's latest annual revenue as reported by LexisNexis*. I used a cut-off of $10 million, which seemed reasonable with respect to the annual revenues being reported by the NYSE- and NASDAQ-listed companies seen previously. I excluded companies that are subsidiaries of other LifeSci/MedTech companies. I did, however, include companies that are owned by private equity.  

Below is the list of privately held TX-based biomedical companies with annual revenues exceeding $10 million:


(Open spreadsheet as a separate page here.)

KCI, a San Antonio-based medical device company specializing in wound care, really stands out from the pack with its annual revenue exceeding its closest competitor's by more than 15-fold**. Overall, I was excited to find a diverse mix of companies working in very different areas: molecular diagnostics, nutritional supplements, Pharma CRO, medical devices, etc. I have to admit, though, that I was somewhat disappointed by the absence from the list of pharma/biotech companies working on developing and selling therapeutic small molecules/biologicals.  


-Isamu Hartman, PhD

(Next post - back to the SBIR database!)


---------------------------------------
* technical note:  In my LexisNexis search I used NAICS codes 32541, 54171, 541512, 334510, 339112, and 339113, and SIC codes 2833, 2834, 2835, 2836, 3821, 3841, 3842, and 8731. 

** KCI, initially a NYSE-listed company, briefly went private from 1997 to 2004 and then became private again when acquired by its current owner, Apax Partners LLP, in 2011 (see http://en.wikipedia.org/wiki/Kinetic_Concepts_Inc, http://www.apax.com/).

Comments

Post a Comment

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman
Post a Comment
Read more

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...
Post a Comment
Read more

Corporate Venture Capital at the Top 10 Pharma/Biotech Companies

Today I'm taking a step outside of Texas and looking at the world. Many large pharmaceutical and biotech firms maintain venture capital operations through which they invest in early-stage biomedical companies. I wanted to get a sense of what these biopharma corporate venture capital (CVC) funds are up to. Which companies have CVC funds? How active are they? What are their goals? What are they investing in? Background: general and sector-specific trends in venture capital In 2014 venture capital funding in the U.S. hit its highest annual mark since 2001, as investors participated in $47.3 billion across 3,617 deals . Within this trend Life Sciences was the second largest sector (behind only the Media and Entertainment sector) for 2014 in dollar terms with $8.6 billion invested in 789 deals, the highest level since 2007 . Corporate venture funding has followed similar trends:  2014 marked the strongest year for CVC activity since 2000 with $5.4 billion invested in U.S.-based co...
Post a Comment
Read more